Consolidated Statements of Cash Flows (Unaudited) (USD $) | | |
In Millions | 9 Months Ended
Oct. 03, 2009
| 9 Months Ended
Sep. 27, 2008
|
Segment Manufacturing Group | | |
Cash flows from operating activities: | | |
Net income (loss) | $194 | $646 |
Income from discontinued operations | 45 | 15 |
Income (loss) from continuing operations | 149 | 631 |
Adjustments to reconcile income (loss) from continuing operations to net cash provided by (used in) operating activities: | | |
Dividends received from the Finance group | 284 | 142 |
Capital contributions paid to Finance group | (197) | 0 |
Non-cash items: | | |
Depreciation and amortization | 270 | 262 |
Asset impairment charges | 54 | 0 |
Gains on extinguishment of debt | (3) | 0 |
Share-based compensation | 24 | 39 |
Amortization of interest expense on convertible notes | 13 | 0 |
Deferred income taxes | (22) | 11 |
Changes in assets and liabilities: | | |
Accounts receivable, net | (14) | (83) |
Inventories | 372 | (773) |
Other assets | (73) | 59 |
Accounts payable | (444) | 220 |
Accrued and other liabilities | (149) | 114 |
Other operating activities, net | 53 | 33 |
Net cash provided by (used in) operating activities of continuing operations | 317 | 655 |
Net cash used in operating activities of discontinued operations | (17) | (21) |
Net cash provided by (used in) operating activities | 300 | 634 |
Cash flows from investing activities: | | |
Net cash used in acquisitions | 0 | (109) |
Capital expenditures | (165) | (310) |
Proceeds from sale of property, plant and equipment | 3 | 4 |
Other investing activities, net | (49) | 0 |
Net cash provided by (used in) investing activities of continuing operations | (211) | (415) |
Net cash provided by (used in) investing activities of discontinued operations | 239 | (10) |
Net cash provided by (used in) investing activities | 28 | (425) |
Cash flows from financing activities: | | |
Increase (decrease) in short-term debt | (869) | 240 |
Proceeds from long-term lines of credit | 1,230 | 0 |
Payments on long-term lines of credit | (58) | 0 |
Proceeds from issuance of long-term debt | 595 | 0 |
Principal payments on long-term debt | (212) | (44) |
Payments on borrowings against officers life insurance policies | (411) | 0 |
Intergroup financing | 133 | 0 |
Proceeds from issuance of convertible notes, net of fees paid | 582 | 0 |
Purchase of convertible note hedge | (140) | 0 |
Proceeds from issuance of common stock and warrants | 333 | 0 |
Proceeds from option exercises | 0 | 40 |
Excess tax benefit on stock options | 0 | 10 |
Purchases of Textron common stock | 0 | (533) |
Dividends paid | (16) | (172) |
Net cash provided by (used in) financing activities of continuing operations | 1,167 | (459) |
Net cash used in financing activities of discontinued operations | 0 | (2) |
Net cash provided by (used in) financing activities | 1,167 | (461) |
Effect of exchange rate changes on cash and cash equivalents | 11 | 2 |
Net increase (decrease) in cash and cash equivalents | 1,506 | (250) |
Cash and cash equivalents at beginning of period | 531 | 471 |
Cash and cash equivalents at end of period | 2,037 | 221 |
Segment Finance Group | | |
Cash flows from operating activities: | | |
Net income (loss) | (162) | 49 |
Income (loss) from continuing operations | (162) | 49 |
Non-cash items: | | |
Depreciation and amortization | 27 | 31 |
Provision for losses on finance receivables held for investment | 206 | 101 |
Portfolio losses on finance receivables | 114 | 0 |
Gains on extinguishment of debt | (48) | 0 |
Deferred income taxes | (116) | (27) |
Changes in assets and liabilities: | | |
Other assets | 8 | 11 |
Accrued and other liabilities | 80 | (6) |
Other operating activities, net | 25 | (5) |
Net cash provided by (used in) operating activities of continuing operations | 134 | 154 |
Net cash provided by (used in) operating activities | 134 | 154 |
Cash flows from investing activities: | | |
Finance receivables originated or purchased | (3,074) | (9,489) |
Finance receivables repaid | 3,860 | 8,602 |
Proceeds on receivables sales, including securitizations | 252 | 746 |
Capital expenditures | 0 | (8) |
Proceeds from sale of repossessed assets and properties | 176 | 0 |
Retained interests | 117 | 11 |
Purchase of marketable securities | 0 | (100) |
Other investing activities, net | 32 | 13 |
Net cash provided by (used in) investing activities of continuing operations | 1,363 | (225) |
Net cash provided by (used in) investing activities | 1,363 | (225) |
Cash flows from financing activities: | | |
Increase (decrease) in short-term debt | (768) | 30 |
Proceeds from long-term lines of credit | 1,740 | 0 |
Proceeds from issuance of long-term debt | 46 | 1,461 |
Principal payments on long-term debt | (1,823) | (1,201) |
Intergroup financing | (112) | 0 |
Capital contributions paid to Finance group | 217 | 0 |
Dividends paid | (284) | (142) |
Net cash provided by (used in) financing activities of continuing operations | (984) | 148 |
Net cash provided by (used in) financing activities | (984) | 148 |
Effect of exchange rate changes on cash and cash equivalents | 10 | (1) |
Net increase (decrease) in cash and cash equivalents | 523 | 76 |
Cash and cash equivalents at beginning of period | 16 | 60 |
Cash and cash equivalents at end of period | 539 | 136 |
Consolidated | | |
Cash flows from operating activities: | | |
Net income (loss) | 32 | 695 |
Income from discontinued operations | 45 | 15 |
Income (loss) from continuing operations | (13) | 680 |
Non-cash items: | | |
Depreciation and amortization | 297 | 293 |
Provision for losses on finance receivables held for investment | 206 | 101 |
Portfolio losses on finance receivables | 114 | 0 |
Asset impairment charges | 54 | 0 |
Gains on extinguishment of debt | (51) | 0 |
Share-based compensation | 24 | 39 |
Amortization of interest expense on convertible notes | 13 | 0 |
Deferred income taxes | (138) | (16) |
Changes in assets and liabilities: | | |
Accounts receivable, net | (14) | (83) |
Inventories | 368 | (787) |
Other assets | (57) | 78 |
Accounts payable | (444) | 220 |
Accrued and other liabilities | (69) | 108 |
Captive finance receivables, net | 187 | (8) |
Other operating activities, net | 78 | 28 |
Net cash provided by (used in) operating activities of continuing operations | 555 | 653 |
Net cash used in operating activities of discontinued operations | (17) | (21) |
Net cash provided by (used in) operating activities | 538 | 632 |
Cash flows from investing activities: | | |
Finance receivables originated or purchased | (2,613) | (8,766) |
Finance receivables repaid | 3,250 | 8,000 |
Proceeds on receivables sales, including securitizations | 202 | 633 |
Net cash used in acquisitions | 0 | (109) |
Capital expenditures | (165) | (318) |
Proceeds from sale of property, plant and equipment | 3 | 4 |
Proceeds from sale of repossessed assets and properties | 176 | 0 |
Retained interests | 117 | 11 |
Purchase of marketable securities | 0 | (100) |
Other investing activities, net | 32 | 19 |
Net cash provided by (used in) investing activities of continuing operations | 1,002 | (626) |
Net cash provided by (used in) investing activities of discontinued operations | 239 | (10) |
Net cash provided by (used in) investing activities | 1,241 | (636) |
Cash flows from financing activities: | | |
Increase (decrease) in short-term debt | (1,637) | 270 |
Proceeds from long-term lines of credit | 2,970 | 0 |
Payments on long-term lines of credit | (58) | 0 |
Proceeds from issuance of long-term debt | 641 | 1,461 |
Principal payments on long-term debt | (2,035) | (1,245) |
Payments on borrowings against officers life insurance policies | (411) | 0 |
Proceeds from issuance of convertible notes, net of fees paid | 582 | 0 |
Purchase of convertible note hedge | (140) | 0 |
Proceeds from issuance of common stock and warrants | 333 | 0 |
Proceeds from option exercises | 0 | 40 |
Excess tax benefit on stock options | 0 | 10 |
Purchases of Textron common stock | 0 | (533) |
Dividends paid | (16) | (172) |
Net cash provided by (used in) financing activities of continuing operations | 229 | (169) |
Net cash used in financing activities of discontinued operations | 0 | (2) |
Net cash provided by (used in) financing activities | 229 | (171) |
Effect of exchange rate changes on cash and cash equivalents | 21 | 1 |
Net increase (decrease) in cash and cash equivalents | 2,029 | (174) |
Cash and cash equivalents at beginning of period | 547 | 531 |
Cash and cash equivalents at end of period | $2,576 | $357 |